Luye Pharma Group Ltd.

Luye Pharma Group Ltd.verified

LYPHF

Price:

$0.3437

Market Cap:

$9.37B

Luye Pharma Group Ltd., an investment holding company, develops, produces, markets, and sells pharmaceutical products worldwide. The company offers Lipusu for ovarian and breast cancer; CMNa, a chemical sensitizer for cancer radiotherapy; Tiandida for ovarian or non-small cell lung cancer; Boyounuo, an injection for the treatment of various types of cancers and other solid tumors; and Xuezhikang, a lipid regulating drug for the treatment of hypercholesterolaemia. It also provides Maitongna for cerebral edema swelling by trauma or surgery, and for venous reflux disorders; Beixi, an acarbose capsule for Type 2 diabetes; Rivastigmine Transdermal Patch for the treatment of Alzheimer's disease; F...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2021-02-18

Stock Exchange

PNK

Ticker

LYPHF

The PE Ratio as of November 2024 (TTM) for Luye Pharma Group Ltd. (LYPHF) is 11.46

According to Luye Pharma Group Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 11.46. This represents a change of -19.43% compared to the average of 14.22 of the last 4 quarters.

Luye Pharma Group Ltd. (LYPHF) Historical PE Ratio (quarterly & annually)

How has LYPHF PE Ratio performed in the past?

The mean historical PE Ratio of Luye Pharma Group Ltd. over the last ten years is 6.39. The current 11.46 PE Ratio has changed 17.85% with respect to the historical average. Over the past ten years (40 quarters), LYPHF's PE Ratio was at its highest in in the March 2023 quarter at 63.44. The PE Ratio was at its lowest in in the September 2021 quarter at -16.13.

Quarterly (TTM)
Annual

Average

6.39

Median

20.34

Minimum

-113.37

Maximum

29.77

Luye Pharma Group Ltd. (LYPHF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Luye Pharma Group Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 219.27%

Maximum Annual PE Ratio = 29.77

Minimum Annual Increase = -613.57%

Minimum Annual PE Ratio = -113.37

Quarterly (TTM)
Annual
YearPE RatioChange
202321.27-28.54%
202229.77-126.26%
2021-113.37-613.57%
202022.0893.82%
201911.39-10.27%
201812.69-21.63%
201716.20-16.50%
201619.40-9.46%
201521.42-6.88%
201423.00219.27%

Luye Pharma Group Ltd. (LYPHF) Average PE Ratio

How has LYPHF PE Ratio performed in the past?

The current PE Ratio of Luye Pharma Group Ltd. (LYPHF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-20.78

5-year avg

-5.77

10-year avg

6.39

Luye Pharma Group Ltd. (LYPHF) PE Ratio vs. Peers

How is LYPHF’s PE Ratio compared to its peers?

Luye Pharma Group Ltd.’s PE Ratio is less than Astellas Pharma Inc. (161.32), greater than Sanofi (8.31), greater than Amarin Corporation plc (-5.73), less than Novartis AG (11.92), greater than Scilex Holding Company (-0.53), less than Biogen Inc. (14.24), less than Gilead Sciences, Inc. (892.59), less than AstraZeneca PLC (31.32), less than Johnson & Johnson (25.44), greater than Bristol-Myers Squibb Company (-16.45), less than AbbVie Inc. (61.11), less than Eli Lilly and Company (80.52), less than Pfizer Inc. (34.12), less than Merck & Co., Inc. (20.67),

Build a custom stock screener for Luye Pharma Group Ltd. (LYPHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Luye Pharma Group Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Luye Pharma Group Ltd. (LYPHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Luye Pharma Group Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Luye Pharma Group Ltd.'s PE Ratio?

How is the PE Ratio calculated for Luye Pharma Group Ltd. (LYPHF)?

What is the highest PE Ratio for Luye Pharma Group Ltd. (LYPHF)?

What is the 3-year average PE Ratio for Luye Pharma Group Ltd. (LYPHF)?

What is the 5-year average PE Ratio for Luye Pharma Group Ltd. (LYPHF)?

How does the current PE Ratio for Luye Pharma Group Ltd. (LYPHF) compare to its historical average?